Read this carefully:

This is a bunch of typical Euro-mumbojumbo.

Europe is offering zero tariffs (that’s a start), but only on industrial goods. Agriculture is off the table. And what about non-tariff barriers?

Consider the pharmaceutical sector, as UP senior research fellow Tomas Philipson notes:

America invents the majority of the world’s new medicines — yet we ran a $117 billion global trade deficit in biopharmaceutical products last year…Foreign price controls are a major reason that America imports so much more than it exports, despite dominating the sector when it comes to research and development…

For decades, European governments have been leeching off American research and development by imposing stringent price controls on drugs.

Those price controls function as a non-tariff trade barrier.

Any trade deal with the EU must require a cessation of all price controls on American-made drugs.